Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Sep;242(1):29-36.
doi: 10.1016/j.atherosclerosis.2015.06.042. Epub 2015 Jul 2.

Liver X receptors at the intersection of lipid metabolism and atherogenesis

Affiliations
Review

Liver X receptors at the intersection of lipid metabolism and atherogenesis

Stephen D Lee et al. Atherosclerosis. 2015 Sep.
No abstract available

Keywords: Atherosclerosis; LXR; Lipid metabolism; Nuclear receptor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
LXRs exert distinct effects on cholesterol and lipid metabolism in discrete cell types. Globally, LXR activation induces reverse cholesterol transport and reduces atherosclerotic plaque burden. Macrophage LXRs respond to oxidized sterol by increasing cholesterol efflux to lipoprotein acceptors, while decreasing uptake through the targeted degradation of the LDL receptor. In hepatocytes, LXRs increase the removal of cholesterol either by conversion to bile acids or direct secretion into the bile by ABC transporters. LXRs also induce a lipogenic program in hepatocytes, leading to increased triglyceride production and secretion. LXR activation in the small intestine decreases cholesterol absorption by increasing the expression of apical efflux transporters. Intestinal LXRs raise circulating HDL levels by inducing the expression of ABCA1. Portions of this figure were modified with permission from Macmillan Publishers Ltd: Nature Reviews Molecular Cell Biology (reference ).
Figure 2
Figure 2
Activation of LXRs is protective at different stages of atherosclerosis. In early lesions, cholesterol accumulates in macrophages, which adopt “foam cell” morphology. LXR activation in these cells reduces inflammation and improves cholesterol efflux. As atherosclerosis progresses the lesions become more complex, characterized by acellular lipid accumulation, a necrotic core, and thinning fibrous cap. In advanced lesions LXR activation induces the expression of genes that increase cholesterol efflux, reduce inflammation, stabilize the fibrous cap, induce macrophage egress from the lesion, repress apoptosis, and improve the clearance of apoptotic debris.-, -, -, , -, , -

References

    1. Goldstein JL, Brown MS. A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins. Cell. 2015;161:161–172. - PMC - PubMed
    1. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952. - PubMed
    1. Yusuf S, Rangarajan S, Teo K, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371:818–827. - PubMed
    1. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79:8–15. - PubMed
    1. Breslow JL. Mouse models of atherosclerosis. Science (New York, N.Y.) 1996;272:685–688. - PubMed

Publication types

MeSH terms